TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17211365

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) and suture in group A
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: PRP, haemostatic sponges and suture in group B
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Haemostatic sponges, suture and compression with gauzes soaked in tranexamic acid in group C
Number of subjects: 208

Group type: COMPARATOR
Intervention: Dicumarol therapy suspended and replaced by heparin-calcium in group D (control group)
Number of subjects: 208
Study: 12950426

Group type: EXPERIMENTAL
Intervention: Lumiracoxib 200 mg twice daily for 8 days
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo for 8 days
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg twice daily for 8 days
Number of subjects: 65
Study: 10984372

Group type: EXPERIMENTAL
Intervention: Basophil surface IgE density and FcepsilonRIalpha expression
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Monocyte FcepsilonRIalpha expression
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Eosinophil FcepsilonRIalpha expression
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: CD23 expression on basophils and eosinophils
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: CD23 expression on monocytes
Number of subjects: 31
Study: 8997579

Group type: EXPERIMENTAL
Intervention: S-shaped haptics lenses (trans-sclerally fixed by two sutures)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sutureless sulcus self-fixation PCL
Number of subjects: 20

Group type: COMPARATOR
Intervention: C-loop posterior chamber lenses (control group)
Number of subjects: 20
Study: 8365011

Group type: EXPERIMENTAL
Intervention: Laser cautery of the inferior turbinates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sub‐mucosal diathermy of the inferior turbinates
Number of subjects: 0
Study: 3533755

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil ester (1.5 g) with probenecid (1.0 g)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Amoxycillin (3.0 g) plus clavulanic acid (0.25 g) with probenecid (1.0 g)
Number of subjects: 500
Study: 30531700

Group type: EXPERIMENTAL
Intervention: 6 sets of squats
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 3 sets of squats
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 12 sets of squats
Number of subjects: 28
Study: 27513157

Group type: COMPARATOR
Intervention: Intra-abdominal drainage
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: No drainage
Number of subjects: 395
Study: 25256866

Group type: EXPERIMENTAL
Intervention: Diurnal sleep (2 hours)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Wakefulness (no sleep)
Number of subjects: 24
Study: 23200600

Group type: EXPERIMENTAL
Intervention: FIL (Flexion in Lying)
Number of subjects: 25

Group type: COMPARATOR
Intervention: EIL (Extension in Lying)
Number of subjects: 25
Study: 21664653

Group type: EXPERIMENTAL
Intervention: Percutaneous nephrolithotomy (PNL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extracorporeal shock wave lithotripsy (ESWL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PNL
Number of subjects: 0

Group type: COMPARATOR
Intervention: ESWL
Number of subjects: 0
Study: 18054443

Group type: EXPERIMENTAL
Intervention: Stepped Care (SC): a computerized intervention plus up to three 40-min telephone-based interventions depending on the success of the previous intervention.
Number of subjects: 10803

Group type: EXPERIMENTAL
Intervention: Full-Care (FC): a computerized intervention plus a fixed number of four 30-min telephone-based interventions.
Number of subjects: 10803

Group type: COMPARATOR
Intervention: Control Group (CG): untreated group.
Number of subjects: 10803
Study: 17319482

Group type: EXPERIMENTAL
Intervention: Single-dose extended-release epidural morphine (EREM) 10, 20, or 30 mg
Number of subjects: 120
Study: 12714115

Group type: EXPERIMENTAL
Intervention: Aspirin (low dose of 100mg daily or less)
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: NSAIDs without aspirin
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Aspirin (for individuals aged 75 years and over)
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Aspirin (for individuals younger than 75 years)
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 1007
Study: 10745145

Group type: EXPERIMENTAL
Intervention: Anxiety reduction protocol including a booklet, tape-recorded demonstration, control room visit, music volume adjustment device, precise scan timings, and visible clock during scanning.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard procedures with limited information given in advance.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Experimental group with anxiety reduction protocol.
Number of subjects: 64
Study: 9374129

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 1539812

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl administration
Number of subjects: 16

Group type: COMPARATOR
Intervention: Intravenous fentanyl administration
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both epidural and intravenous fentanyl
Number of subjects: 16
Study: 3993611

Group type: EXPERIMENTAL
Intervention: USDA Women, Infants and Children (WIC) Food Supplementation vouchers
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: USDA Women, Infants and Children (WIC) Food Supplementation vouchers (in smokers)
Number of subjects: 410

Group type: COMPARATOR
Intervention: No supplementation (Control)
Number of subjects: 410
Study: 30396739

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation preoperatively
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline treatment
Number of subjects: 60
Study: 28575379

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (n=121)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo (n=91)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 212
Study: 26853645

Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (standard treatment with compression stockings and anticoagulants)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Catheter-directed thrombolysis and Control group
Number of subjects: 176
Study: 23446197

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate (PP; 234 mg day 1 and 156 mg day 8)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Risperidone long-acting injection (RLAI; 25 mg, days 8 and 22)
Number of subjects: 292
Study: 22836068

Group type: EXPERIMENTAL
Intervention: Metformin plus colesevelam (3.75 g/day)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Metformin plus placebo
Number of subjects: 286
Study: 20731985

Group type: EXPERIMENTAL
Intervention: Living with heavy drinkers
Number of subjects: 2649

Group type: EXPERIMENTAL
Intervention: Knowing heavy drinkers outside the household
Number of subjects: 2649

Group type: EXPERIMENTAL
Intervention: Heavy drinkers within the household
Number of subjects: 2649
Study: 17505461

Group type: EXPERIMENTAL
Intervention: Prophylactic cerclage (electively performed at 13-16 weeks gestation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic cerclage (urgent or emergent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transvaginal cerclage (McDonald technique)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transabdominal cerclage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic cerclage
Number of subjects: 0
Study: 15958080

Group type: EXPERIMENTAL
Intervention: Alicaforsen (ISIS 2302)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study: 12235612

Group type: EXPERIMENTAL
Intervention: Clinical examination of the abdomen by abdominal palpation and suprapubic percussion
Number of subjects: 16

Group type: COMPARATOR
Intervention: Portable ultrasound findings
Number of subjects: 16
Study: 10616677

Group type: EXPERIMENTAL
Intervention: Initial assessment and management by specially trained physiotherapists (orthopaedic physiotherapy specialists)
Number of subjects: 481

Group type: COMPARATOR
Intervention: Initial assessment and management by post‐Fellowship junior orthopaedic surgeons
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Physiotherapist arm
Number of subjects: 481

Group type: COMPARATOR
Intervention: Doctor arm
Number of subjects: 481
Study: 7553993

Group type: EXPERIMENTAL
Intervention: Propofol/alfentanil (Group Prop)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Isoflurane/alfentanil (Group Iso)
Number of subjects: 27
Study: 1443441

Group type: EXPERIMENTAL
Intervention: 0.75 ml/kg alcohol
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 6371696

Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (steroids)
Number of subjects: 696

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 696
Study: 31803473

Group type: EXPERIMENTAL
Intervention: Lebrikizumab (anti-IL-13)
Number of subjects: 2148
Study: 28805455

Group type: EXPERIMENTAL
Intervention: Telephone-based peer support intervention (weekly calls for six weeks)
Number of subjects: 185
Study: 27087149

Group type: EXPERIMENTAL
Intervention: AMA1 vaccine candidate
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control rabies vaccine
Number of subjects: 400
Study: 24419993

Group type: EXPERIMENTAL
Intervention: No Excuses/Sin buscar excusas (adapted VOICES intervention)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 370
Study: 22162463

Group type: EXPERIMENTAL
Intervention: Mandometer (intervention group)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 27
Study: 19926634

Group type: EXPERIMENTAL
Intervention: Tranexamic acid 15 mg/kg given at skin incision and 3 hours later
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 110
Study: 16931057

Group type: EXPERIMENTAL
Intervention: Time-space synaesthesia individuals
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Month names
Number of subjects: 4
Study: 16145639

Group type: EXPERIMENTAL
Intervention: 0.125 % bupivacaine plus 1 microg x ml (‐1) fentanyl
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.125 % bupivacaine plus 0.75 microg x ml (‐1) clonidine
Number of subjects: 75

Group type: COMPARATOR
Intervention: 0.125 % bupivacaine
Number of subjects: 75
Study: 12116326

Group type: EXPERIMENTAL
Intervention: Pulsed Nd:YAG laser treatment
Number of subjects: 194

Group type: COMPARATOR
Intervention: Drill treatment
Number of subjects: 194
Study: 10416251

Group type: EXPERIMENTAL
Intervention: Heated aerosol exposure (hyperthermal 43.0 degrees C) for 10 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: No heated aerosol exposure (control)
Number of subjects: 0
Study: 7562751

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Auranofin
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 132
Study: 2286697

Group type: EXPERIMENTAL
Intervention: Titrated dose of midazolam to produce light or heavy sedation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Midazolam (all treatment levels)
Number of subjects: 18
Study: 7048922

Group type: EXPERIMENTAL
Intervention: Topical acyclovir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 0
Study: 31812681

Group type: EXPERIMENTAL
Intervention: Diet M (monounsaturated fat‐enriched diet)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Diet P (polyunsaturated-fat enriched diet)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Diet M and Diet P
Number of subjects: 362
Study: 31336184

Group type: EXPERIMENTAL
Intervention: Luteal phase support with hCG (1500 IU, two injections at three days interval)
Number of subjects: 300

Group type: COMPARATOR
Intervention: No luteal phase support
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 300
Study: 29293879

Group type: EXPERIMENTAL
Intervention: Hummocks burnt 6 months after the 2012 mast event
Number of subjects: 200

Group type: COMPARATOR
Intervention: Hummocks burnt but prevented from masting by clipping inflorescences
Number of subjects: 200
Study: 26784672

Group type: EXPERIMENTAL
Intervention: Laparoscopic lavage
Number of subjects: 83

Group type: COMPARATOR
Intervention: Hartmann procedure
Number of subjects: 83
Study: 24178807

Group type: EXPERIMENTAL
Intervention: 4 mg intravitreal triamcinolone acetonide (IVTA) injection
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (non-treated patients)
Number of subjects: 36
Study: 21862138

Group type: EXPERIMENTAL
Intervention: Duloxetine 120 mg daily
Number of subjects: 49

Group type: COMPARATOR
Intervention: Bupropion 300 mg daily
Number of subjects: 49
Study: 19158194

Group type: EXPERIMENTAL
Intervention: pioglitazone (30 mg/d)
Number of subjects: 40
Study: 17482941

Group type: EXPERIMENTAL
Intervention: Verapamil 10 mg/20 mL (Group 3)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Verapamil 10 mg/4 mL (Group 1)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Verapamil 10 mg/10 mL (Group 2)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 77
Study: 14693983

Group type: EXPERIMENTAL
Intervention: Inhaled fast‐acting human insulin via AERx iDMS
Number of subjects: 107

Group type: COMPARATOR
Intervention: Subcutaneous fast‐acting human insulin
Number of subjects: 107
Study: 12235606

Group type: EXPERIMENTAL
Intervention: Supported treadmill ambulation training (STAT)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Regular intervention (control)
Number of subjects: 13
Study: 9795350

Group type: EXPERIMENTAL
Intervention: 20 mg prednisolone twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7986457

Group type: EXPERIMENTAL
Intervention: Discontinuation of antihypertensive medication with no dietary intervention
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Discontinuation of antihypertensive medication with sodium restriction
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Discontinuation of antihypertensive medication with weight reduction for the obese
Number of subjects: 496

Group type: COMPARATOR
Intervention: Control group (return to antihypertensive medication)
Number of subjects: 496
Study: 2590608

Group type: EXPERIMENTAL
Intervention: Intravenous oxpentifylline (200 mg in 10 ml saline)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (10 ml saline)
Number of subjects: 8
Study: 30039897

Group type: EXPERIMENTAL
Intervention: Zirconia restorations
Number of subjects: 40

Group type: COMPARATOR
Intervention: Metal-Ceramic (MC) restorations
Number of subjects: 40
Study: 28419982

Group type: EXPERIMENTAL
Intervention: Resting Heart Rate (RHR) <64 beats/min
Number of subjects: 2060

Group type: EXPERIMENTAL
Intervention: Resting Heart Rate (RHR) 64-70 beats/min
Number of subjects: 2060

Group type: EXPERIMENTAL
Intervention: Resting Heart Rate (RHR) 71-79 beats/min
Number of subjects: 2060

Group type: EXPERIMENTAL
Intervention: Resting Heart Rate (RHR) >79 beats/min
Number of subjects: 2060

Group type: EXPERIMENTAL
Intervention: RHR as a continuous variable
Number of subjects: 2060
Study: 25930041

Group type: EXPERIMENTAL
Intervention: Online training plus an online learning collaborative supported by expert clinicians
Number of subjects: 36

Group type: COMPARATOR
Intervention: In-person training with local supervision
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Internet-supported e-learning
Number of subjects: 36

Group type: COMPARATOR
Intervention: In-person training
Number of subjects: 36
Study: 23512957

Group type: EXPERIMENTAL
Intervention: Breakfast group (700 kcal breakfast, 500 kcal lunch, 200 kcal dinner)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dinner group (200 kcal breakfast, 500 kcal lunch, 700 kcal dinner)
Number of subjects: 100
Study: 21491295

Group type: EXPERIMENTAL
Intervention: Motivation Enhancement Therapy (MET)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Peer-delivered 12-step facilitation (P-TSF)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 150

Group type: COMPARATOR
Intervention: All groups (TAU, MET, P-TSF)
Number of subjects: 150
Study: 19657294

Group type: EXPERIMENTAL
Intervention: Antioxidants (AOX) supplementation (272 mg of alpha‐tocopherol, 400 mg of vitamin C, 30 mg of beta‐carotene, 2 mg of lutein, 400 mcg of selenium, 30 mg of zinc, and 600 mg of magnesium)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Antioxidants (AOX) supplementation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 17118826

Group type: EXPERIMENTAL
Intervention: Myocardial perfusion scintigraphy (MPS)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Serial ECG recordings and measurements of CK-MB and cTnT
Number of subjects: 102
Study: 15286093

Group type: EXPERIMENTAL
Intervention: Fexofenadine 120 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cetirizine 20 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hydroxyzine 30 mg (positive control)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10931124

Group type: EXPERIMENTAL
Intervention: Warfarin treatment
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9443523

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg daily)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 8340309

Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.4 mg/kg/day)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fenfluramine (gradually increased to 1.5 mg/kg/day)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Methylphenidate and Fenfluramine
Number of subjects: 28
Study: 3566109

Group type: EXPERIMENTAL
Intervention: Gritti-Stokes amputations
Number of subjects: 22

Group type: COMPARATOR
Intervention: Through-knee amputations
Number of subjects: 22
Study: 31764209

Group type: EXPERIMENTAL
Intervention: Continuous Skin-to-Skin Contact (SSC)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Intermittent Skin-to-Skin Contact (SSC)
Number of subjects: 31
Study: 29502529

Group type: EXPERIMENTAL
Intervention: Therapeutic horseback riding (THR) for 6 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Wait-list control group (no intervention for 6 weeks)
Number of subjects: 29
Study: 27185412

Group type: EXPERIMENTAL
Intervention: High-protein soyabean curd
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-protein soyabean curd with polydextrose
Number of subjects: 27

Group type: COMPARATOR
Intervention: Low-protein soyabean curd
Number of subjects: 27
Study: 24884466

Group type: EXPERIMENTAL
Intervention: Falls Efficacy Scale‐International (FES‐I)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Swedish FES (FES(S))
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Activities‐specific Balance Confidence scale (ABC)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: modified Survey of Activities and Fear of Falling in the Elderly (mSAFFE)
Number of subjects: 174
Study: 22440640

Group type: EXPERIMENTAL
Intervention: Cell salvage group (17 patients)
Number of subjects: 34
Study: 21078810

Group type: EXPERIMENTAL
Intervention: Prescription omega-3 (8 g/d for the first 7 days, then 4 g/d through week 24)
Number of subjects: 663

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: Prescription omega-3
Number of subjects: 663
Study: 18246283

Group type: EXPERIMENTAL
Intervention: Tier 1 Program of Project P.A.T.H.S.
Number of subjects: 8255

Group type: COMPARATOR
Intervention: Control schools (no intervention)
Number of subjects: 8255
Study: 15975461

Group type: EXPERIMENTAL
Intervention: Sensar OptiEdge AR40e intraocular lens (sharp posterior optic edge)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sensar AR40 intraocular lens (double-round edge design)
Number of subjects: 53
Study: 12627311

Group type: EXPERIMENTAL
Intervention: Hypoxia (H, 14.5% O(2)) at workloads WL1, WL2, WL3
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normoxia (N) at workloads WL1, WL2, WL3
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ventilatory response to isocapnic hypoxia (VRH)
Number of subjects: 20
Study: 10556607

Group type: EXPERIMENTAL
Intervention: Prefrontal lesioned patients
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 2
Study: 8908223

Group type: EXPERIMENTAL
Intervention: Propofol induction at 133 mg · min‐1
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Propofol requirement
Number of subjects: 21
Study: 1713352

Group type: EXPERIMENTAL
Intervention: clomipramine 150 mgr/die
Number of subjects: 68

Group type: COMPARATOR
Intervention: maprotiline/oxaprotiline 150 mgr/die
Number of subjects: 68

Group type: COMPARATOR
Intervention: both groups (clomipramine and maprotiline/oxaprotiline)
Number of subjects: 68
Study: 6126399

Group type: EXPERIMENTAL
Intervention: Oxatomide (60 mg daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Mequitazine (10 mg daily)
Number of subjects: 26
Study: 30871561

Group type: EXPERIMENTAL
Intervention: Patient-centered deprescribing intervention initiated in the hospital and continued in the PAC setting
Number of subjects: 576

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Patient-centered deprescribing intervention
Number of subjects: 576
Study: 28357404

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency (PRF) combined with pharmacological therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pharmacological therapy
Number of subjects: 40
Study: 26153838

Group type: EXPERIMENTAL
Intervention: Laryngeal reinnervation
Number of subjects: 17

Group type: COMPARATOR
Intervention: Thyroplasty
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Voice Handicap Index 10
Number of subjects: 17
Study: 24274317

Group type: EXPERIMENTAL
Intervention: Proposed herbal moisturising cream containing Arctium lappa L. seed extract
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 66